Laughlin M - Search Results

1

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, Ciocci G, Carrier C, Stevens CE, Rubinstein P. Kurtzberg J, et al. Among authors: laughlin m. N Engl J Med. 1996 Jul 18;335(3):157-66. doi: 10.1056/NEJM199607183350303. N Engl J Med. 1996. PMID: 8657213 Free article. Clinical Trial.

2

Unrelated umbilical cord blood transplantation in adult patients.

Long GD, Laughlin M, Madan B, Kurtzberg J, Gasparetto C, Morris A, Rizzieri D, Smith C, Vredenburgh J, Halperin EC, Broadwater G, Niedzwiecki D, Chao NJ. Long GD, et al. Among authors: laughlin m. Biol Blood Marrow Transplant. 2003 Dec;9(12):772-80. doi: 10.1016/j.bbmt.2003.08.007. Biol Blood Marrow Transplant. 2003. PMID: 14677117 Free article.

3

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.

Laughlin MJ, Rizzieri DA, Smith CA, Moore JO, Lilly S, McGaughey D, Martin P, Carrier C, Stevens CE, Rubinstein P, Buckley R, Kurtzberg J. Laughlin MJ, et al. Leuk Res. 1998 Mar;22(3):215-9. doi: 10.1016/s0145-2126(97)00171-9. Leuk Res. 1998. PMID: 9619913 No abstract available.

4

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. Laughlin MJ, et al. N Engl J Med. 2001 Jun 14;344(24):1815-22. doi: 10.1056/NEJM200106143442402. N Engl J Med. 2001. PMID: 11407342 Free article. Clinical Trial.

5

Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration.

Wadhwa PD, Lazarus HM, Koc ON, Jaroscak J, Woo D, Stevens CE, Rubinstein P, Laughlin MJ. Wadhwa PD, et al. Among authors: laughlin mj. Leuk Res. 2003 Mar;27(3):215-20. doi: 10.1016/s0145-2126(02)00090-5. Leuk Res. 2003. PMID: 12537973 Clinical Trial.

6

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM. Laughlin MJ, et al. N Engl J Med. 2004 Nov 25;351(22):2265-75. doi: 10.1056/NEJMoa041276. N Engl J Med. 2004. PMID: 15564543 Free article.

7

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

Graham ML, Herndon JE 2nd, Casey JR, Chaffee S, Ciocci GH, Krischer JP, Kurtzberg J, Laughlin MJ, Longee DC, Olson JF, Paleologus N, Pennington CN, Friedman HS. Graham ML, et al. Among authors: laughlin mj. J Clin Oncol. 1997 May;15(5):1814-23. doi: 10.1200/JCO.1997.15.5.1814. J Clin Oncol. 1997. PMID: 9164190

8

Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia.

Graham ML, Asselin BL, Herndon JE 2nd, Casey JR, Chaffee S, Ciocci GH, Daeschner CW, Davis AR, Gold S, Halperin EC, Laughlin MJ, Martin PL, Olson JF, Kurtzberg J. Graham ML, et al. Among authors: laughlin mj. Bone Marrow Transplant. 1998 May;21(9):879-85. doi: 10.1038/sj.bmt.1701223. Bone Marrow Transplant. 1998. PMID: 9613779 Clinical Trial.

9

A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.

Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P, Ross M, Gilbert C, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin M, Kurtzberg J, Peters WP. Elkordy M, et al. Among authors: laughlin m. Bone Marrow Transplant. 1997 Feb;19(4):315-22. doi: 10.1038/sj.bmt.1700633. Bone Marrow Transplant. 1997. PMID: 9051240 Clinical Trial.

10

Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.

Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J. Laughlin MJ, et al. Ann Hematol. 1993 Dec;67(6):267-76. doi: 10.1007/BF01696346. Ann Hematol. 1993. PMID: 7506580 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters